News | May 07, 2023
Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
The collaboration between CORONA and Ferring will cater to patients across India
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
Nous-209 has been developed using the Nouscom's viral vector platform
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Subscribe To Our Newsletter & Stay Updated
